{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T07:43:55Z","timestamp":1769240635086,"version":"3.49.0"},"reference-count":37,"publisher":"American Society for Microbiology","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Gamma interferon (IFN-\u03b3) release assays (IGRAs) are used increasingly for the periodic tuberculosis (TB) screening of health care workers (HCWs), although data regarding the reproducibility and interpretation of serial testing results in countries with a low incidence of TB are scarce. The present study evaluated and compared the within-subject variability of dichotomous and continuous results of two commercial IGRAs, the QuantiFERON-TB Gold In-Tube (QFT) and the T-SPOT.TB (T-SPOT), in German HCWs during a 4-week period. Thirty-five immunocompetent HCWs with low or medium TB screening risk and without known recent TB exposure or tuberculin skin test application were tested repeatedly with both IGRAs at weekly intervals. A total of 158 valid results were obtained for each IGRA. Changes of about \u00b170% (QFT) and \u00b160% (T-SPOT) from the mean IFN-\u03b3 response accounted for 95% of the within-subject variability. However, according to the manufacturers' cutoffs, inconsistent results were observed more frequently for the QFT (28.6%; four conversions, six reversions) than for the T-SPOT (8.6%; three reversions;<jats:italic>P<\/jats:italic>&lt; 0.001). The overall agreement between the IGRAs was good. Regression toward the means accounted for a significant decline in mean IFN-\u03b3 responses of about 25% between successive visits for both IGRAs. Although both assays were highly reliable and reproducible, we observed substantial within-subject variability and regression toward the means during a 4-week period, which should be considered when interpreting serial testing results in comparable populations and settings. Our data support the use of borderline zones for the interpretation of serial IGRA results and the retesting of borderline positive results before offering preventive chemotherapy.<\/jats:p>","DOI":"10.1128\/cvi.05058-11","type":"journal-article","created":{"date-parts":[[2011,5,19]],"date-time":"2011-05-19T03:36:31Z","timestamp":1305776191000},"page":"1176-1182","source":"Crossref","is-referenced-by-count":57,"title":["Within-Subject Variability of Mycobacterium tuberculosis-Specific Gamma Interferon Responses in German Health Care Workers"],"prefix":"10.1128","volume":"18","author":[{"given":"Felix C.","family":"Ringshausen","sequence":"first","affiliation":[]},{"given":"Albert","family":"Nienhaus","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Torres Costa","sequence":"additional","affiliation":[]},{"given":"Heiko","family":"Knoop","sequence":"additional","affiliation":[]},{"given":"Stephan","family":"Schl\u00f6sser","sequence":"additional","affiliation":[]},{"given":"Gerhard","family":"Schultze-Werninghaus","sequence":"additional","affiliation":[]},{"given":"Gernot","family":"Rohde","sequence":"additional","affiliation":[]}],"member":"235","published-online":{"date-parts":[[2011,5,18]]},"reference":[{"key":"key20180919073522_B1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ije\/dyh299","article-title":"Regression to the mean: what it is and how to deal with it","volume":"34","author":"Barnett","year":"2005","journal-title":"Int. J. Epidemiol."},{"key":"key20180919073522_B2","first-page":"A4101","article-title":"Diagnosis of latent tuberculosis infection in U.S. health care workers: reproducibility, repeatability and 6 month follow-up with interferon-gamma release assays (IGRAs)","volume":"179","author":"Belknap","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"key20180919073522_B3","unstructured":"Cellestis. \n2007. QuantiFERON\u00ae-TB Gold In-Tube package insert. Cellestis, Melbourne, Australia. http:\/\/www.cellestis.com\/IRM\/Company\/ShowPage.aspx?CPID=1255."},{"issue":"RR-17","key":"key20180919073522_B4","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005","volume":"54","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"MMWR Recomm. Rep."},{"key":"key20180919073522_B5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1086\/599284","article-title":"Use of a T cell interferon-gamma release assay to evaluate tuberculosis risk in newly qualified physicians in Singapore healthcare institutions","volume":"30","author":"Chee","year":"2009","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"key20180919073522_B6","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/CVI.00168-09","article-title":"Short-term reproducibility of a commercial interferon gamma release assay","volume":"16","author":"Detjen","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073522_B7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-2007-959219","article-title":"Recommendations for background studies in tuberculosis","volume":"61","author":"Diel","year":"2007","journal-title":"Pneumologie"},{"key":"key20180919073522_B8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","article-title":"Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis","volume":"37","author":"Diel","year":"2011","journal-title":"Eur. Respir. J."},{"key":"key20180919073522_B9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.09-2350","article-title":"Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis","volume":"137","author":"Diel","year":"2010","journal-title":"Chest"},{"key":"key20180919073522_B10","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2307\/2531727","article-title":"An approach to the analysis of repeated measurements","volume":"44","author":"Diggle","year":"1988","journal-title":"Biometrics"},{"key":"key20180919073522_B11","article-title":"Use of interferon-gamma release assays in support of TB diagnosis","author":"European Centre for Disease Prevention and Control","year":"2011"},{"key":"key20180919073522_B12","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"key20180919073522_B13","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1086\/648082","article-title":"Annual incidence of latent tuberculosis infection among newly employed nurses at a tertiary care university hospital","volume":"30","author":"Lee","year":"2009","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"key20180919073522_B14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1183\/09031936.00120908","article-title":"LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement","volume":"33","author":"Mack","year":"2009","journal-title":"Eur. Respir. J."},{"key":"key20180919073522_B15","first-page":"49","article-title":"Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States","volume":"54","author":"Mazurek","year":"2005","journal-title":"MMWR Recomm. Rep."},{"key":"key20180919073522_B16","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm. Rep."},{"key":"key20180919073522_B17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","article-title":"Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion","volume":"159","author":"Menzies","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"key20180919073522_B18","first-page":"593","article-title":"Risk of tuberculosis infection and disease associated with work in health care settings","volume":"11","author":"Menzies","year":"2007","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"key20180919073522_B19","unstructured":"Oxford Immunotec. \n2009. T-SPOT.TB package insert (PI-TB8-IVD-UK-V5). Oxford Immunotec, Abingdon, United Kingdom. http:\/\/www.oxfordimmunotec.com\/8-UK."},{"key":"key20180919073522_B20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1164\/rccm.200604-472OC","article-title":"Serial testing of health care workers for tuberculosis using interferon-gamma assay","volume":"174","author":"Pai","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"key20180919073522_B21","first-page":"84","article-title":"T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India","volume":"13","author":"Pai","year":"2009","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"key20180919073522_B22","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1371\/journal.pmed.0040208","article-title":"Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?","volume":"4","author":"Pai","year":"2007","journal-title":"PLoS Med."},{"key":"key20180919073522_B23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"key20180919073522_B24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/CVI.00398-07","article-title":"Reproducibility of QuantiFERON-TB gold in-tube assay","volume":"15","author":"Perry","year":"2008","journal-title":"Clin. Vaccine Immunol."},{"key":"key20180919073522_B25","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/590262","article-title":"Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution?","volume":"29","author":"Pollock","year":"2008","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"key20180919073522_B26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2334-10-220","article-title":"Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers","volume":"10","author":"Ringshausen","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"key20180919073522_B27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1745-6673-4-11","article-title":"In-hospital contact investigation among health care workers after exposure to smear-negative tuberculosis","volume":"4","author":"Ringshausen","year":"2009","journal-title":"J. Occup. Med. Toxicol."},{"key":"key20180919073522_B28","article-title":"Angewandte statistik: anwendung statistischer methoden","author":"Sachs","year":"2003","edition":"11th ed."},{"key":"key20180919073522_B29","first-page":"Doc05","article-title":"Serial testing with an interferon-gamma release assay in German healthcare workers. GMS Krankenhhyg","volume":"5","author":"Schablon","year":"2010","journal-title":"Interdiszip."},{"key":"key20180919073522_B30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000086261","article-title":"Review of epidemiological studies on the occupational risk of tuberculosis in low-incidence areas","volume":"72","author":"Seidler","year":"2005","journal-title":"Respiration"},{"key":"key20180919073522_B31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00420-010-0571-x","article-title":"Serial testing with the interferon-gamma release assay in Portuguese healthcare workers","volume":"84","author":"Torres Costa","year":"2011","journal-title":"Int. Arch. Occup. Environ. Health"},{"key":"key20180919073522_B32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.200811-1704OC","article-title":"Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing","volume":"180","author":"van Zyl-Smit","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"key20180919073522_B33","doi-asserted-by":"crossref","first-page":"e8517","DOI":"10.1371\/journal.pone.0008517","article-title":"Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review","volume":"4","author":"van Zyl-Smit","year":"2009","journal-title":"PLoS One"},{"key":"key20180919073522_B34","doi-asserted-by":"crossref","first-page":"e1850","DOI":"10.1371\/journal.pone.0001850","article-title":"T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data","volume":"3","author":"Veerapathran","year":"2008","journal-title":"PLoS One"},{"key":"key20180919073522_B35","article-title":"WHO policy on TB infection control in health-care facilities, congregate settings and households","author":"World Health Organization","year":"2009"},{"key":"key20180919073522_B36","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1017\/S0950268809002751","article-title":"Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-gamma assays","volume":"137","author":"Yoshiyama","year":"2009","journal-title":"Epidemiol. Infect."},{"key":"key20180919073522_B37","doi-asserted-by":"crossref","unstructured":"ZwerlingA.\nvan den HofS.\nScholtenJ.\nCobelensF.\nMenziesD.\nPaiM.. \n12 January 2011, posting date. Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review. Thorax doi: 10.1136\/thx.2010.143180.","DOI":"10.1136\/thx.2010.143180"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.05058-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:45:19Z","timestamp":1627591519000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.05058-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,18]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7,5]]},"published-print":{"date-parts":[[2011,7]]}},"alternative-id":["10.1128\/CVI.05058-11"],"URL":"https:\/\/doi.org\/10.1128\/cvi.05058-11","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,18]]}}}